Should You Buy Vertex Pharmaceuticals on the Dip Before Potentially Enormous News in January 2025?
22/12 10:30
Vertex Pharmaceuticals (NASDAQ: VRTX) was on track to become one of this year's biotech winners, with the shares climbing 27% from January through a peak in November. The company, the global leader in cystic fibrosis (CF) treatments, has established a long track record of earning...